Myriad Genetics announced that Jan Schlüchter will be its new chief commercial officer starting Oct. 15. Schlüchter will lead operations in Europe and guide commercialization efforts around Myriad's tests. In his new role, Schlüchter will report to Gary King, Myriad's executive VP of international operations.
Schlüchter previously held various senior posts at Novartis and most recently was global head of key account management at the firm's headquarters in Basel, Switzerland. Before joining Novartis, Schlüchter was a consultant at McKinsey.